Search - tctmd.com

Displaying 1 - 20 of 52

Sort: Relevancy | Date

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

News Conference News EuroPCR 2025

OCT-Guided PCI Bests Angiography in ACS Patients: OCCUPI

May 28, 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

News Conference News EuroPCR 2025

Stroke Risk Higher With TAVI vs Surgery at 5 Years: UK TAVI

Michael O'Riordan

May 23, 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

News Conference News EuroPCR 2025

Lower MACE Risk With FFR- vs Angio-Guided PCI in AS Patients: FAITAVI

May 22, 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

News Conference News EuroPCR 2025

Higher Mortality With TAVI Over Surgery in Bicuspid Aortic Stenosis

Michael O'Riordan

May 22, 2025

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

News Conference News EuroPCR 2024

FFR-Derived Metric Can Identify Focal CAD Best Suited to PCI

May 20, 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

News Conference News EuroPCR 2024

ShortCut Leaflet Splitter Proves Safe, May Streamline Valve-in-Valve TAVI

May 16, 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presentation EuroPCR 2024

Is coronary artery bypass surgery cost-effective compared with contemporary PCI? A FAME 3 analysis

Presenter: Frederik Zimmermann

May 15, 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presentation EuroPCR 2024

Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study.

Presenter: Mateusz Tajstra

May 15, 2024

Debate Continues on TAVI Choice for Women With Small Annuli

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

News Conference News EuroPCR 2023

Registry Data Support TAVI in AS Patients With Cardiogenic Shock

May 16, 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

News Conference News EuroPCR 2023

Virtual, Dynamic Coronary Map Cuts Contrast During PCI: DCR4Contrast

May 16, 2023

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

News Conference News EuroPCR 2022

CCTA Increases Contrast Volume in Patients With Prior CABG: GREECE Trial

Yael L. Maxwell

May 24, 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

News Conference News EuroPCR 2022

Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

Michael O'Riordan

May 23, 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI ROLEX

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

May 18, 2022

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

News Conference News EuroPCR 2021

Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

May 21, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.